Total amount: € 0,00
Indexed/Abstracted in: EMBASE, Scopus
Online ISSN 1827-188X
Fischetto D., Marioni G., Marchese-Ragona R., Staffieri A.
Department of Medical and Surgical Specialties Section of Otolaryngology University of Padova, Padova, Italy
Laryngeal carcinoma is the 11th commonest form of cancer in men world-wide with about 52 000 new cases/year in Europe, and approximately 9 500-11 000 in the United States. The evolution of laryngeal carcinoma treatment could be divided into 3 main eras. The 1st was focused on curing patients using radical procedures, mainly by total laryngectomy. The 2nd era had the goal of voice preservation respecting oncological principles. The current one is based on organ sparing protocols utilizing a combination of radiation, chemotherapy and surgery. Optimal patient selection and tailored indications increase the likelihood of a successful outcome of treatment. The modern approach to laryngeal carcinoma needs a specialized team including head and neck surgeons, radiotherapists, medical oncologists, pathologists, speech and swallow therapists.